{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:52:18Z","timestamp":1791215538458,"version":"4.1.0"},"reference-count":71,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:sec id=\"ab-ioi260043-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Medicare Advantage (MA) costs 22% more than original Medicare (OM) for a given individual ($83 billion in annual excess public costs). However, MA may improve type 2 diabetes (T2D) outcomes compared with OM by providing financial protections (eg, annual out-of-pocket spending caps) and supplemental benefits (eg, healthy food assistance) that OM cannot.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ioi260043-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine whether MA coverage is associated with better T2D outcomes than OM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ioi260043-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>A longitudinal cohort study using target trial emulation principles for design and analysis in adults aged 18 years or older receiving OM or MA with T2D, followed up before and after Medicare coverage in community-based health centers (January 2021 to June 2024) across 44 states. Analyses were conducted from September 2025 to May 2026.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ioi260043-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>MA or OM coverage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ioi260043-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>\n                      Hemoglobin A\n                      <jats:sub>1c<\/jats:sub>\n                      (HbA\n                      <jats:sub>1c<\/jats:sub>\n                      ) (primary outcome), systolic blood pressure (SBP) and diastolic blood pressure (DBP), low-density lipoprotein (LDL) cholesterol, food insecurity, housing instability, and transportation barriers at 12 months after Medicare coverage (primary time point) and at 6, 18, and 24 months. Statistical analysis accounted for pre-Medicare coverage factors that may influence selection of MA vs OM using targeted minimum loss estimation. Covariates were age, sex, race and ethnicity, comorbidities, income, Social Vulnerability Index, pre-Medicare insurance, Medicaid coverage, and pre-Medicare coverage values for HbA\n                      <jats:sub>1c<\/jats:sub>\n                      , SBP, DBP, LDL cholesterol, body mass index, food insecurity, housing instability, and transportation barriers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ioi260043-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In this study in 34\u202f648 adults (19\u202f054 in OM, 15\u202f594 in MA) with T2D, followed up before and after Medicare coverage, the mean (SD) age was 65.24 (9.73) years and 53.42% were women. Twelve months after Medicare coverage, MA was not associated with better HbA\n                      <jats:sub>1c<\/jats:sub>\n                      (mean difference, 0.01; 95% CI, \u22120.04 to 0.05,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.74), SBP (\u22120.15; 95% CI, \u22120.54 to 0.24;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.44), DBP (0.06; 95% CI, \u22120.15 to 0.27;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.58), or LDL cholesterol (\u22120.41; 95% CI, \u22121.24 to 0.42;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.33), with similar results at other time points. MA was also not associated with a lower risk of food insecurity (relative risk [RR], 1.00; 95% CI, 0.94-1.05), housing instability (RR, 1.00; 95% CI, 0.91-1.09), or transportation barriers (RR, 1.00; 95% CI, 0.93-1.07) at 12 months or any other time point.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ioi260043-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this study, when accounting for factors that may drive MA selection, MA was not associated with better T2D outcomes or fewer health-related social needs than OM. Given substantially higher spending for MA, it is important to ensure this spending is being used effectively to improve health.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamainternmed.2026.3332","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:00:32Z","timestamp":1786374032000},"page":"1246","source":"Crossref","is-referenced-by-count":0,"title":["Medicare Advantage and Type 2 Diabetes Outcomes"],"prefix":"10.1001","volume":"186","author":[{"given":"Seth A.","family":"Berkowitz","sequence":"first","affiliation":[{"name":"Division of General Medicine and Clinical Epidemiology, Department of Medicine, University of North Carolina at Chapel Hill School of Medicine"},{"name":"Center for Health Promotion and Disease Prevention, University of North Carolina at Chapel Hill School of Medicine"},{"name":"Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myklynn","family":"LaPoint","sequence":"additional","affiliation":[{"name":"Center for Health Promotion and Disease Prevention, University of North Carolina at Chapel Hill School of Medicine"},{"name":"Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlena L.","family":"Kuhn","sequence":"additional","affiliation":[{"name":"Department of Social Medicine, Center for Thriving Communities, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Basu","sequence":"additional","affiliation":[{"name":"Clinical Product Development, Waymark Care, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Hudgens","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Gold","sequence":"additional","affiliation":[{"name":"Department of Research, OCHIN, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungchul","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, College of Health Science, Korea University, Seoul, Republic of Korea"},{"name":"L-HOPE Program for Community-Based Total Learning Health Systems, Korea University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"ioi260043r2","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.2337\/dc25-S001","article-title":"1. Improving care and promoting health in populations: standards of care in diabetes\u20142025.","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","journal-title":"Diabetes Care"},{"issue":"9","key":"ioi260043r3","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.2337\/dci23-0002","article-title":"Food insecurity and diabetes: overview of intersections and potential dual solutions.","volume":"46","author":"Levi","year":"2023","journal-title":"Diabetes Care"},{"issue":"1","key":"ioi260043r4","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2337\/dci20-0053","article-title":"Social determinants of health and diabetes: a scientific review.","volume":"44","author":"Hill-Briggs","year":"2020","journal-title":"Diabetes Care"},{"issue":"18","key":"ioi260043r5","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1161\/CIR.0000000000001182","article-title":"Food is medicine: a presidential advisory from the American Heart Association.","volume":"148","author":"Volpp","year":"2023","journal-title":"Circulation"},{"issue":"8","key":"ioi260043r6","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.jacc.2023.12.023","article-title":"\u201cFood is medicine\u201d strategies for nutrition security and cardiometabolic health equity: JACC state-of-the-art review.","volume":"83","author":"Mozaffarian","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"ioi260043r7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1177\/1524839920945927","article-title":"Food insecurity and mortality in American adults: results from the NHANES-linked mortality study.","volume":"22","author":"Banerjee","year":"2021","journal-title":"Health Promot Pract"},{"issue":"4","key":"ioi260043r8","doi-asserted-by":"publisher","DOI":"10.1111\/dme.15268","article-title":"Association between adult food insecurity and mortality among adults aged 20-79?years with diabetes: A population-based retrospective cohort study.","volume":"41","author":"Fu","year":"2024","journal-title":"Diabet Med"},{"key":"ioi260043r9","doi-asserted-by":"publisher","DOI":"10.5888\/pcd15.180058","article-title":"Incremental health care costs associated with food insecurity and chronic conditions among older adults.","volume":"15","author":"Garcia","year":"2018","journal-title":"Prev Chronic Dis"},{"issue":"10","key":"ioi260043r10","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s12603-015-0639-0","article-title":"Food insecurity and peripheral arterial disease in older adult populations.","volume":"20","author":"Redmond","year":"2016","journal-title":"J Nutr Health Aging"},{"issue":"1","key":"ioi260043r11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000357595","article-title":"Effect of food insecurity on chronic kidney disease in lower-income Americans.","volume":"39","author":"Crews","year":"2014","journal-title":"Am J Nephrol"},{"issue":"9","key":"ioi260043r12","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1007\/s11606-019-04992-x","article-title":"Food insecurity, eye care receipt, and diabetic retinopathy among US adults with diabetes: implications for primary care.","volume":"34","author":"Gibson","year":"2019","journal-title":"J Gen Intern Med"},{"issue":"6","key":"ioi260043r13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179172","article-title":"Trends in food insecurity for adults with cardiometabolic disease in the United States: 2005-2012.","volume":"12","author":"Berkowitz","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"ioi260043r14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1089\/dia.2014.0166","article-title":"Quantifying direct effects of social determinants of health on glycemic control in adults with type 2 diabetes.","volume":"17","author":"Walker","year":"2015","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"ioi260043r15","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.25996","article-title":"Social risk and clinical outcomes among adults with type 2 diabetes.","volume":"7","author":"Walker","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"2","key":"ioi260043r16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1001\/jamainternmed.2014.6888","article-title":"Material need insecurities, control of diabetes mellitus, and use of health care resources: results of the Measuring Economic Insecurity in Diabetes Study.","volume":"175","author":"Berkowitz","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"1","key":"ioi260043r17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1001\/jamainternmed.2018.5008","article-title":"Cost-related insulin underuse among patients with diabetes.","volume":"179","author":"Herkert","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"5","key":"ioi260043r18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.12147","article-title":"Diabetes care barriers, use, and health outcomes in younger adults with type 1 and type 2 diabetes.","volume":"6","author":"Pihoker","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"13","key":"ioi260043r20","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1007\/s11606-024-08798-4","article-title":"Financial hardship among Traditional Medicare and Medicare Advantage enrollees with and without food insecurity.","volume":"39","author":"Park","year":"2024","journal-title":"J Gen Intern Med"},{"issue":"5","key":"ioi260043r21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.14211","article-title":"Cost-related medication nonadherence and desire for medication cost information among adults aged 65 years and older in the US in 2022.","volume":"6","author":"Dusetzina","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"23","key":"ioi260043r25","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1056\/NEJMp1803292","article-title":"Integrating medical and nonmedical services\u2014the promise and pitfalls of the CHRONIC Care Act.","volume":"378","author":"Willink","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"ioi260043r29","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.15058","article-title":"New supplemental benefits and plan ratings among Medicare Advantage enrollees.","volume":"7","author":"Tucher","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"6","key":"ioi260043r30","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1377\/hlthaff.2020.02149","article-title":"Comparing Medicare Advantage and Traditional Medicare: a systematic review.","volume":"40","author":"Agarwal","year":"2021","journal-title":"Health Aff (Millwood)"},{"issue":"4","key":"ioi260043r31","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1377\/hlthaff.2022.00891","article-title":"Differences in use of services and quality of care in Medicare Advantage and Traditional Medicare, 2010 and 2017.","volume":"42","author":"Landon","year":"2023","journal-title":"Health Aff (Millwood)"},{"issue":"9","key":"ioi260043r32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.37765\/ajmc.2021.88641","article-title":"Quality, health, and spending in Medicare Advantage and traditional Medicare.","volume":"27","author":"DuGoff","year":"2021","journal-title":"Am J Manag Care"},{"issue":"9","key":"ioi260043r33","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2022.2935","article-title":"Comparison of low-value services among Medicare Advantage and Traditional Medicare beneficiaries.","volume":"3","author":"Boudreau","year":"2022","journal-title":"JAMA Health Forum"},{"issue":"8","key":"ioi260043r34","first-page":"559","article-title":"A comparison of relative resource use and quality in Medicare Advantage health plans versus traditional Medicare.","volume":"21","author":"Landon","year":"2015","journal-title":"Am J Manag Care"},{"issue":"11","key":"ioi260043r35","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1097\/MLR.0000000000001390","article-title":"Differences in health care utilization, process of diabetes care, care satisfaction, and health status in patients with diabetes in Medicare Advantage versus traditional Medicare.","volume":"58","author":"Park","year":"2020","journal-title":"Med Care"},{"issue":"3","key":"ioi260043r36","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.37765\/ajmc.2021.88602","article-title":"Use of diabetes medications in traditional Medicare and Medicare Advantage.","volume":"27","author":"Landon","year":"2021","journal-title":"Am J Manag Care"},{"issue":"7","key":"ioi260043r37","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.2337\/dc21-1178","article-title":"Diabetes care among older adults enrolled in Medicare Advantage versus traditional Medicare fee-for-service plans: the Diabetes Collaborative Registry.","volume":"45","author":"Essien","year":"2022","journal-title":"Diabetes Care"},{"issue":"11","key":"ioi260043r38","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.125.012143","article-title":"Cardiovascular risk factor management in Medicare Advantage and traditional Medicare.","volume":"18","author":"Oseran","year":"2025","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"ioi260043r39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ssmph.2024.101709","article-title":"Estimating the impact of addressing food needs on diabetes outcomes.","volume":"27","author":"Berkowitz","year":"2024","journal-title":"SSM Popul Health"},{"issue":"12","key":"ioi260043r40","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1136\/jech-2025-224037","article-title":"Heterogeneity in associations between food insecurity and diabetes outcomes.","volume":"79","author":"Berkowitz","year":"2025","journal-title":"J Epidemiol Community Health"},{"issue":"5","key":"ioi260043r41","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1370\/afm.2275","article-title":"Adoption of social determinants of health EHR tools by community health centers.","volume":"16","author":"Gold","year":"2018","journal-title":"Ann Fam Med"},{"issue":"4","key":"ioi260043r42","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3122\/jabfm.2017.04.170046","article-title":"Developing electronic health record (EHR) strategies related to health center patients\u2019 social determinants of health.","volume":"30","author":"Gold","year":"2017","journal-title":"J Am Board Fam Med"},{"issue":"1","key":"ioi260043r43","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/aje\/kwu255","article-title":"Trends in diabetes incidence among 7 million insured adults, 2006-2011: the SUPREME-DM project.","volume":"181","author":"Nichols","year":"2015","journal-title":"Am J Epidemiol"},{"issue":"Suppl 3","key":"ioi260043r44","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.14443","article-title":"Identification of social risk-related referrals in discrete primary care electronic health record data: lessons learned from a novel methodology.","volume":"60","author":"Dankovchik","year":"2025","journal-title":"Health Serv Res"},{"issue":"1","key":"ioi260043r45","doi-asserted-by":"publisher","DOI":"10.1017\/cts.2023.680","article-title":"Area-level social determinants of health and individual-level social risks: assessing predictive ability and biases in social risk screening.","volume":"7","author":"Bensken","year":"2023","journal-title":"J Clin Transl Sci"},{"issue":"12","key":"ioi260043r50","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1097\/MLR.0000000000000824","article-title":"Adaptation and validation of the combined comorbidity score for ICD-10-CM.","volume":"55","author":"Sun","year":"2017","journal-title":"Med Care"},{"issue":"12","key":"ioi260043r51","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1001\/jama.2025.13350","article-title":"Transparent reporting of observational studies emulating a target trial\u2014the TARGET Statement.","volume":"334","author":"Cashin","year":"2025","journal-title":"JAMA"},{"issue":"2","key":"ioi260043r52","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2202\/1557-4679.1211","article-title":"Targeted maximum likelihood based causal inference: part I.","volume":"6","author":"van der Laan","year":"2010","journal-title":"Int J Biostat"},{"issue":"2","key":"ioi260043r53","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2202\/1557-4679.1241","article-title":"Targeted maximum likelihood based causal inference: part II.","volume":"6","author":"van der Laan","year":"2010","journal-title":"Int J Biostat"},{"issue":"0","key":"ioi260043r54","first-page":"1","article-title":"Nonparametric causal effects based on longitudinal modified treatment policies.","volume":"0","author":"D\u00edaz","year":"2021","journal-title":"J Am Stat Assoc"},{"issue":"5","key":"ioi260043r55","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/EDE.0000000000001764","article-title":"Studying continuous, time-varying, and\/or complex exposures using longitudinal modified treatment policies.","volume":"35","author":"Hoffman","year":"2024","journal-title":"Epidemiology"},{"issue":"1","key":"ioi260043r57","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1515\/jci-2013-0019","article-title":"Assumption trade-offs when choosing identification strategies for pre-post treatment effect estimation: an illustration of a community-based intervention in Madagascar.","volume":"3","author":"Weber","year":"2015","journal-title":"J Causal Inference"},{"issue":"9","key":"ioi260043r58","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1377\/hlthaff.2022.01525","article-title":"Favorable selection in Medicare Advantage is linked to inflated benchmarks and billions in overpayments to plans.","volume":"42","author":"Ryan","year":"2023","journal-title":"Health Aff (Millwood)"},{"issue":"5","key":"ioi260043r59","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1377\/hlthaff.2019.01070","article-title":"Switching between Medicare Advantage and traditional Medicare before and after the onset of functional disability.","volume":"39","author":"Ankuda","year":"2020","journal-title":"Health Aff (Millwood)"},{"issue":"11","key":"ioi260043r62","doi-asserted-by":"publisher","first-page":"e563","DOI":"10.1161\/CIR.0000000000000677","article-title":"2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"11","key":"ioi260043r63","first-page":"e114","article-title":"2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"152","author":"Jones","year":"2025","journal-title":"Circulation"},{"issue":"18","key":"ioi260043r66","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1001\/jama.2015.15281","article-title":"Multiple imputation: a flexible tool for handling missing data.","volume":"314","author":"Li","year":"2015","journal-title":"JAMA"},{"issue":"4","key":"ioi260043r67","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1377\/hlthaff.2018.05390","article-title":"Adjusted mortality rates are lower for Medicare Advantage than traditional Medicare, but the rates converge over time.","volume":"38","author":"Newhouse","year":"2019","journal-title":"Health Aff (Millwood)"},{"issue":"4","key":"ioi260043r68","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/j.0006-341X.2001.01030.x","article-title":"Causal inference on the difference of the restricted mean lifetime between two groups.","volume":"57","author":"Chen","year":"2001","journal-title":"Biometrics"},{"issue":"2","key":"ioi260043r69","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/1740774518759281","article-title":"Restricted mean survival time: does covariate adjustment improve precision in randomized clinical trials?","volume":"15","author":"Karrison","year":"2018","journal-title":"Clin Trials"},{"issue":"11","key":"ioi260043r70","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1001\/jamacardio.2017.2922","article-title":"Restricted mean survival time as a measure to interpret clinical trial results.","volume":"2","author":"Kim","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"2","key":"ioi260043r71","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1353\/obs.2023.0019","article-title":"lmtp: An R package for estimating the causal effects of modified treatment policies.","volume":"9","author":"Williams","year":"2023","journal-title":"Obs Stud"},{"key":"ioi260043r1","unstructured":"Centers for Disease Control and Prevention. National Diabetes Statistics Report. Diabetes. November 29, 2023. Accessed May 1, 2024. https:\/\/www.cdc.gov\/diabetes\/data\/statistics-report\/index.html"},{"key":"ioi260043r19","doi-asserted-by":"crossref","unstructured":"Rabbitt? MP, Reed-Jones? M, Hales? LJ, Burke? MP. Household food security in the United States in 2023. Accessed October 3, 2024. https:\/\/www.ers.usda.gov\/publications\/pub-details\/?pubid=109895","DOI":"10.32747\/2024.8583175.ers"},{"key":"ioi260043r22","unstructured":"Centers for Medicare & Medicaid Services. 2021 MCBS PUF on financial well-being of Medicare beneficiaries. Accessed January 8, 2025. https:\/\/www.cms.gov\/data-research\/research\/medicare-current-beneficiary-survey\/data-tables\/2021-mcbs-puf-financial-well-being-medicare-beneficiaries"},{"key":"ioi260043r23","unstructured":"Commonwealth Fund. Paying for it: how health care costs and medical debt are making Americans sicker and poorer. October 26, 2023. Accessed May 29, 2026. https:\/\/www.commonwealthfund.org\/publications\/surveys\/2023\/oct\/paying-for-it-costs-debt-americans-sicker-poorer-2023-affordability-survey"},{"key":"ioi260043r24","unstructured":"MedPAC. Chapter 12: The Medicare Advantage program: status report (March 2024 report). Accessed May 30, 2024. https:\/\/www.medpac.gov\/document\/chapter-12-the-medicare-advantage-program-status-report-march-2024-report\/"},{"key":"ioi260043r26","unstructured":"Freed? M, Biniek? JF, Damico? A, Published? TN. Medicare Advantage in 2024: premiums, out-of-pocket limits, supplemental benefits, and prior authorization. KFF. August 8, 2024. Accessed December 7, 2024. https:\/\/www.kff.org\/medicare\/issue-brief\/medicare-advantage-in-2024-premiums-out-of-pocket-limits-supplemental-benefits-and-prior-authorization\/"},{"key":"ioi260043r27","unstructured":"MedPAC. March 2024 Report to the Congress: Medicare Payment Policy\u2014MedPAC. Accessed December 7, 2024. https:\/\/www.medpac.gov\/document\/march-2024-report-to-the-congress-medicare-payment-policy\/"},{"key":"ioi260043r28","unstructured":"United Healthcare Group. Medicare Advantage is addressing social determinants of health at scale to improve health outcomes and advance health equity. Accessed May 13, 2026. https:\/\/www.unitedhealthgroup.com\/content\/dam\/UHG\/PDF\/2023\/2023-MA-Social-Determinants-Brief.pdf"},{"key":"ioi260043r46","unstructured":"National Association of Community Health Centers (NACHC). PRAPARE. Accessed August 20, 2019. https:\/\/www.nachc.org\/research-and-data\/prapare\/"},{"key":"ioi260043r47","unstructured":"CMS. The Accountable Health Communities Health-Related Social Needs Screening Tool. Accessed September 28, 2019. https:\/\/innovation.cms.gov\/Files\/worksheets\/ahcm-screeningtool.pdf"},{"key":"ioi260043r48","unstructured":"Kaiser Permanente. Risk Screening Tools Review. Accessed September 12, 2019. https:\/\/sdh-tools-review.kpwashingtonresearch.org\/"},{"key":"ioi260043r49","unstructured":"Centers for Disease Control and Prevention. CDC\/ATSDR Social Vulnerability Index (SVI). February 23, 2024. Accessed March 28, 2024. https:\/\/www.atsdr.cdc.gov\/placeandhealth\/svi\/index.html"},{"key":"ioi260043r56","unstructured":"Hoffman? KL, Salazar-Barreto? D, Rudolph? KE, D\u00edaz? I. Introducing longitudinal modified treatment policies: a unified framework for studying complex exposures.? arXiv. Preprint revised May 14, 2024. https:\/\/doi.org\/10.48550\/arXiv.2304.09460"},{"key":"ioi260043r60","unstructured":"McWilliams? JM. Don\u2019t look up? Medicare Advantage\u2019s trajectory and the future of Medicare. Health Aff Forefront. March 24, 2022. Accessed May 6, 2022. https:\/\/www.healthaffairs.org\/do\/10.1377\/forefront.20220323.773602\/full\/"},{"key":"ioi260043r61","unstructured":"US Food and Drug Administration. Diabetes mellitus: developing drugs and therapeutic biologics for treatment and prevention. March 13, 2019. Accessed August 7, 2019. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/diabetes-mellitus-developing-drugs-and-therapeutic-biologics-treatment-and-prevention"},{"key":"ioi260043r64","unstructured":"Food and Drug Administration. Assessment of pressor effects of drugs: guidance for industry. 2022. Accessed February 6, 2026. https:\/\/www.fda.gov\/media\/113477\/download"},{"key":"ioi260043r65","unstructured":"van Buuren? S, Groothuis-Oudshoorn? K, Vink? G, . Mice: multivariate imputation by chained equations. Published online June 5, 2023. Accessed March 8, 2024. https:\/\/cran.r-project.org\/web\/packages\/mice\/index.html"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2852477\/jamainternal_berkowitz_2026_oi_260043_1789769200.98687.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:01:05Z","timestamp":1791212465000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2852477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":71,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2026.3332","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,1]]}}}